Novo Nordisk Foundation grants EUR 300m to new research center
The Novo Nordisk Foundation's biggest research center investment to date, a sum of EUR 300m, will enable future stem cell research. The grant supports the dream of curing chronic diseases, says Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation.
by ANDREAS LØNSTRUP, translated by daniel pedersen
An investment of EUR 300m over ten years has been granted to a new international stem cell research center, dubbed Renew – the sum is the biggest grant that the Novo Nordisk Foundation has ever given to a research center, Danish media Berlingske reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk wants to innovate in new ways to find cures
For subscribers
